The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy

Current Opinion in Cardiology

Volumn 28, Issue 1, 2013, Pages 50-54

  Gasparini, Maurizio ^a   Galimberti, Paola ^a   Ceriotti, Carlo ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

atrioventricular nodal ablation; biventricular pacing percentage; cardiac resynchronization therapy

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ABLATION THERAPY; ACUTE HEART FAILURE; ATRIOVENTRICULAR CONDUCTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CLINICAL PRACTICE; ELECTROCARDIOGRAPHY; EXERCISE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; SINUS RHYTHM; SURVIVAL RATE; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CATHETER ABLATION; HEART FAILURE; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84871625721     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32835b0b17     Document Type: Review

References (14)

1. Epstein AE, DiMarcoJP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee toRevise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation 2008; 117:e350-e408.
2. Moss AJ, Hall WJ, Cannom DS, et al. MADIT-CRT Trial Investigators. Cardiacresynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361:1329-1338.
3. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Authors/Task Force Members. Eur J Heart Fail 2012; 14:803-869.
4. Gasparini M, AuricchioA, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. JACC 2006; 48:734-743. (Pubitemid 44175735)
5. Gasparini M, AuricchioA, Metra M, et al. Multicentre Longitudinal Observational Study (MILOS) Group. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008; 29:1644-1652. (Pubitemid 351957539)
6. Hayes DL, Boehmer J, Day J. Cardiac resynchronization therapy and relationship of percentage biventricular pacing. Heart Rhythm 2011; 8:1469-1475.
7. Koplan BA, Kaplan AJ, Weiner S, et al. Heart failure decompensation and allcause mortality in relation topercentage biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 2009; 53:355-360.
8. Martin DO, Lemke B, Birnie D, et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 2012; 9:1807-1814.
9. Kamath GS, Cotiga D, Koneru JN, et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol 2009; 53:1050-1055.
10. Gasparini M, Regoli F, Galimberti P, et al. Cardiac resynchronization therapy in heart failure patients with atrial fibrillation. Europace 2009; 11 (Suppl 5): v82-v86.
11. Ganesan A, Brooks A, Roberts-Thompson, et al. Role of AV nodal ablation in cardiac resynchronization therapy in patients with coexistent atrial fibrillation and heart failure: a systematic review. J Am Coll Cardiol 2012; 59: 719-726.
12. Gasparini M, Galimberti P. AV junction ablation in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy: the picture is now clear! J Am Coll Cardiol 2012; 59:727-729.
13. Gasparini M, Steinberg JS, Arshad A, et al. Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur Heart J 2010; 31:976-983.
14. Delnoy PP, Ottervanger JP, Luttikhuis HO, et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 2007; 99:1252-1257. (Pubitemid 46659863)